Promoting better use of medicines through the establishment of a National Essential Medicines Committee in Swaziland

The WHO estimates that more than 50% of all medicines are prescribed, dispensed or sold inappropriately, and that 50% of all patients fail to take them correctly. The overuse, underuse or misuse of medicines—also known as irrational use of medicines—results in wastage of scarce resources, increased risk of adverse drug reactions, and widespread health hazards, including antimicrobial resistance. In Swaziland, the USAID-funded Systems for Improving Access to Pharmaceuticals and Services Program identified two major factors contributing to irrational use of medicines:

  • Polypharmacy, with the average number of medicines per prescription being double (3.33 -3.60) the number recommended by the WHO (1.6-1.8).
  • Overuse of antibiotics, with SIAPS findings showing that in 59% of patient visits to health facilities result in antibiotics prescriptions (well above the 20%-26.8% of cases that the WHO estimates actually require antibiotics).

In 2012, as part of its efforts to promote the rational use of medicines by doctors and patients, the Swaziland Ministry of Health (MOH) developed its first-edition Standard Treatment Guidelines and Essential Medicines List (STG/EML). The standard treatment guidelines (STGs) are meant to assist health care practitioners to make appropriate clinical decisions at all levels of the health care system, including in the private sector. The document was developed with the ultimate goal of optimizing patient care and treatment outcomes through rational medicine use promotion.

Download this article as a PDF

Establishing the National Essential Medicines Committee

To further encourage rational medicine use and minimise the underuse, overuse and incorrect use of medicines, the WHO recommends the establishment of a multi-disciplinary national body to coordinate policies on medicine use. For this reason, the Ministry of Health commissioned the establishment of a National Essential Medicines Committee (NEMC) to maintain a transparent and rigorous process for implementing and updating the STG/EML.

The primary objectives of the NEMC are to:

  • Oversee the implementation of STG/EML
  • Ensure user compliance with the STG/EML
  • Promote rational medicine use
  • Undertake period review of and update the STG/EML
  • Provide oversight of the Pharmaceutical and Therapeutics Committees in health facilities.

 To ensure that the STG/EML remains relevant to the local context and in line with local developments in medicines and the management of priority conditions, the NEMC will select which medicines are considered essential for the Swaziland public health sector; determine at which level/s of care the selected essential medicines shall be available; and devise a mechanism for purchasing pharmaceuticals which are not included in the EML.

Composition of the NEMC

The NEMC comprises health professionals, including clinicians, nurses and pharmacists, with a number of key competencies and areas of expertise, including:

  • Principles of therapeutics
  • Drug supply management
  • Pharmaceutical policy matters
  • Public health interest
  • Public health and primary health care experience
  • Members of functional PTCs
  • Pharmacology
  • Pharmacoeconomics

The NEMC can also co-opt persons on an ad-hoc basis when necessary. These could include members representing specialized national clinical programs dealing with priority health areas like HIV/AIDS, malaria or TB, as well as other medical specialists; epidemiologists; members of the public and national health laboratory representative. Consultations can also take place with professional bodies, pharmaceutical manufacturers, or consumer agencies.

Discussing work plans at the first meeting of the NEMC in June 2014.

Discussing work plans at the first meeting of the NEMC in June 2014.

First Meeting

SIAPS supported the first meeting of the NEMC in June 2014, where a work plan was developed to guide the work of the Committee. Some of the priority issues identified were:

  • The review of the STG to include relevant priority conditions that are currently not part of the document.
  • The review of the EML in accordance with facility VEN analyses to inform the next tender for medicines and medical supplies.
  • The consideration of the reviewed NCD protocol
  • The development of a formulary and policies for more efficient management of the ICU medicines budget

The establishment of the NEMC is a commendable stride that clearly demonstrates the MOH’s commitment to the promotion of rational medicine use, ensuring supply of and access to medicine, the promotion of patient safety, and the minimisation of medicine cost to the Swazi population.

, , , ,

Trackbacks/Pingbacks

  1. Never Had a Herpes Outbreak? Does it Mean You're Not Infected?; The CBCD … | Herpes Survival Kit - February 3, 2016

    […] viruses). Therefore, health care practitioners should recommend Gene-Eden-VIR as a safe and …The first study concluded: "… the clinical study showed that Gene-Eden-VIR is a safe and effe… […]

Leave a Reply